SRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge
SRx Health Solutions (NYSE American: SRXH) said it hedged its decentralized finance (DeFi) portfolio by investing in gold and reduced its hedge on emerging markets.
Rhea-AI Summary
SRx Health Solutions (NYSE American: SRXH) said it hedged its decentralized finance (DeFi) portfolio by investing in gold and reduced its hedge on emerging markets. The company has entered into a definitive merger agreement with EMJ Crypto Technologies and intends to file a Form S-4 to register stock for the proposed transaction.
The communication emphasizes the forthcoming Registration Statement, cautions investors to read the Information Statement/Prospectus, and notes no offer or solicitation is being made at this time.
Positive
- Definitive merger agreement signed with EMJ Crypto Technologies
- Filed intent to register common stock via Form S-4
- Hedged DeFi exposure by investing in gold
Negative
- Proposed issuance of common stock for transaction implies potential dilution
- Reduced emerging-market hedge may increase exposure to EM risks
Details
News Market Reaction – SRXH
On Mar 25, the day this news came out, SRXH closed 3.62% below the previous close.
Data tracked by StockTitan Argus for the Mar 25 session.
Previous Crypto Reports
-
Hedged crypto and emerging-markets portfolio after EMJX merger agreement.
-
Increased Opendoor stake and moved to net long Bitcoin and Ethereum.
-
Significantly reduced crypto short positions to nearly zero amid volatility.
-
Deployed initial $10 million into Bitcoin, Ethereum and select tokens.
-
Sold Solana and bought Ethereum as part of treasury diversification.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
decentralized finance (defi) financial
registration statement on form s-4 regulatory
registration statement regulatory
information statement/prospectus regulatory
securities act regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTH PALM BEACH, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced hedging its decentralized finance (DeFi) portfolio with investment in Gold. The Company has also reduced its hedge on emerging markets.
Michael Young, Director of SRx Health, commented, "We are looking forward to the closing of EMJX in the near future."
Additional Information and Where to Find It
In connection with the proposed transaction between the Company and EMJX intends to file with the SEC a Registration Statement on Form S-4 (the "Registration Statement") to register the common stock to be issued in connection with the proposed transaction. The Registration Statement will include an information statement of the Company and a prospectus of the Company (the "Information Statement/Prospectus"), and each of EMJX and the Company may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement is declared effective, the definitive Information Statement/Prospectus will be sent to the stockholders This is not a substitute for the Registration Statement, the Information Statement/Prospectus or any other relevant documents that EMJX or the Company has filed or will file with the SEC. BEFORE MAKING ANY INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO CAREFULLY AND ENTIRELY READ THE REGISTRATION STATEMENTAND INFORMATION STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT EMJX, THE COMPANY, THE PROPOSED TRANSACTION, AND RELATED MATTERS. A copy of the Registration Statement, Information Statement/Prospectus, as well as other relevant documents filed by EMJX and the Company with the SEC, may be obtained free of charge, when they become available, at the SEC's website at www.sec.gov. The information on EMJX's or the Company's respective websites is not, and shall not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.
No Offer or Solicitation
This communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.
Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
valter@kcsa.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.